Dorman Products, Inc. DORM
136.07 USD -3.26 (-2.34%)
At closeNov 3, 2026, 4:00 PM EST
136.07 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
135.60 Day range 140.68
98.45 52-week range 155.37
- YTD
- +10.46%
- 1 year
- +1.86%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 158.13 +16.2% upside
Now 136.07
- Target (low)
- 150.00
- Target (mean)
- 158.13
- Target (high)
- 165.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy2
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.90 | 1.77 – 1.94 | 2.17 | -12.6% | 552.68M | +2.7% | 8 |
| Next quarter | 2.02 | 1.64 – 2.30 | 1.57 | +28.4% | 546.04M | +3.3% | 7 |
| Current year | 8.63 | 8.50 – 8.67 | 8.87 | -2.7% | 2.19B | +2.7% | 8 |
| Next year | 9.11 | 8.84 – 9.29 | 8.63 | +5.6% | 2.29B | +4.7% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | Freedom Broker | Upgrade | Hold | Buy |
| Oct 23, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 5, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 21, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 4, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Mar 18, 2026 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Mar 5, 2026 | Barrington Research | Maintained | Outperform | Outperform |
| Mar 5, 2026 | Freedom Broker | Maintained | Buy | Buy |
| Mar 2, 2026 | Jefferies | Upgrade | Hold | Buy |
| Feb 27, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 29, 2025 | Freedom Broker | Maintained | Buy | Buy |
| Sep 30, 2025 | Stephens & Co. | Initiated | — | Overweight |
| Sep 18, 2025 | BMO Capital | Initiated | — | Outperform |
| Aug 26, 2025 | Roth Capital | Maintained | Buy | Buy |
| Aug 22, 2025 | Wells Fargo | Initiated | — | Overweight |
| Nov 4, 2024 | Roth MKM | Reiterated | Buy | Buy |
| Jun 14, 2024 | Roth MKM | Reiterated | Buy | Buy |
| Mar 25, 2024 | Roth MKM | Reiterated | Buy | Buy |
| Feb 27, 2024 | Barrington Research | Reiterated | Outperform | Outperform |
| Jul 28, 2023 | Barrington Research | Reiterated | Outperform | Outperform |
| May 3, 2023 | Stephens & Co. | Maintained | — | Equal-Weight |
| May 3, 2023 | Barrington Research | Maintained | — | Outperform |
| Mar 2, 2023 | Stephens & Co. | Maintained | — | Equal-Weight |
| Mar 2, 2023 | Barrington Research | Maintained | — | Outperform |
| Oct 25, 2022 | MKM Partners | Maintained | — | Buy |
| Oct 25, 2022 | Barrington Research | Maintained | — | Outperform |
| Oct 25, 2022 | Stephens & Co. | Maintained | — | Equal-Weight |
| Aug 22, 2022 | Stephens & Co. | Maintained | — | Equal-Weight |
| May 19, 2022 | MKM Partners | Initiated | — | Buy |
| Apr 28, 2020 | Stephens & Co. | Maintained | — | Equal-Weight |
